Biomarkers in community-acquired pneumonia: A state-of-the-art review

Community-acquired pneumonia (CAP) exhibits mortality rates, between 20% and 50% in severe cases. Biomarkers are useful tools for searching for antibiotic therapy modifications and for CAP diagnosis, prognosis and follow-up treatment. This non-systematic state-of-the-art review presents the biologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Seligman, Renato, Ramos-Lima, Luis Francisco, do Amaral Oliveira, Vivian, Sanvicente, Carina, Pacheco, Elyara F., Rosa, Karoline Dalla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488993/
https://www.ncbi.nlm.nih.gov/pubmed/23184211
http://dx.doi.org/10.6061/clinics/2012(11)17
_version_ 1782248707847094272
author Seligman, Renato
Ramos-Lima, Luis Francisco
do Amaral Oliveira, Vivian
Sanvicente, Carina
Pacheco, Elyara F.
Rosa, Karoline Dalla
author_facet Seligman, Renato
Ramos-Lima, Luis Francisco
do Amaral Oliveira, Vivian
Sanvicente, Carina
Pacheco, Elyara F.
Rosa, Karoline Dalla
author_sort Seligman, Renato
collection PubMed
description Community-acquired pneumonia (CAP) exhibits mortality rates, between 20% and 50% in severe cases. Biomarkers are useful tools for searching for antibiotic therapy modifications and for CAP diagnosis, prognosis and follow-up treatment. This non-systematic state-of-the-art review presents the biological and clinical features of biomarkers in CAP patients, including procalcitonin, C-reactive protein, copeptin, pro-ANP (atrial natriuretic peptide), adrenomedullin, cortisol and D-dimers.
format Online
Article
Text
id pubmed-3488993
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
record_format MEDLINE/PubMed
spelling pubmed-34889932012-11-06 Biomarkers in community-acquired pneumonia: A state-of-the-art review Seligman, Renato Ramos-Lima, Luis Francisco do Amaral Oliveira, Vivian Sanvicente, Carina Pacheco, Elyara F. Rosa, Karoline Dalla Clinics (Sao Paulo) Review Community-acquired pneumonia (CAP) exhibits mortality rates, between 20% and 50% in severe cases. Biomarkers are useful tools for searching for antibiotic therapy modifications and for CAP diagnosis, prognosis and follow-up treatment. This non-systematic state-of-the-art review presents the biological and clinical features of biomarkers in CAP patients, including procalcitonin, C-reactive protein, copeptin, pro-ANP (atrial natriuretic peptide), adrenomedullin, cortisol and D-dimers. Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2012-11 /pmc/articles/PMC3488993/ /pubmed/23184211 http://dx.doi.org/10.6061/clinics/2012(11)17 Text en Copyright © 2012 Hospital das Clínicas da FMUSP http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Seligman, Renato
Ramos-Lima, Luis Francisco
do Amaral Oliveira, Vivian
Sanvicente, Carina
Pacheco, Elyara F.
Rosa, Karoline Dalla
Biomarkers in community-acquired pneumonia: A state-of-the-art review
title Biomarkers in community-acquired pneumonia: A state-of-the-art review
title_full Biomarkers in community-acquired pneumonia: A state-of-the-art review
title_fullStr Biomarkers in community-acquired pneumonia: A state-of-the-art review
title_full_unstemmed Biomarkers in community-acquired pneumonia: A state-of-the-art review
title_short Biomarkers in community-acquired pneumonia: A state-of-the-art review
title_sort biomarkers in community-acquired pneumonia: a state-of-the-art review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488993/
https://www.ncbi.nlm.nih.gov/pubmed/23184211
http://dx.doi.org/10.6061/clinics/2012(11)17
work_keys_str_mv AT seligmanrenato biomarkersincommunityacquiredpneumoniaastateoftheartreview
AT ramoslimaluisfrancisco biomarkersincommunityacquiredpneumoniaastateoftheartreview
AT doamaraloliveiravivian biomarkersincommunityacquiredpneumoniaastateoftheartreview
AT sanvicentecarina biomarkersincommunityacquiredpneumoniaastateoftheartreview
AT pachecoelyaraf biomarkersincommunityacquiredpneumoniaastateoftheartreview
AT rosakarolinedalla biomarkersincommunityacquiredpneumoniaastateoftheartreview

Ejemplares similares